Status:
COMPLETED
Impact Nerium Oleander on Immune Function
Lead Sponsor:
HealthQuilt
Conditions:
Covid19 Positive Patient
Covid19 Close Contact
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Assess the impact of a proprietary extract of Nerium oleander on immune function as evidenced by COVID-19 symptoms and mortality in COVID-19 positive patients and their close contacts compared to cont...
Detailed Description
This is an exploratory study based on positive in-vitro, and in-vivo (humans) that appear to support an immune function benefit. Up to 100 patients that are COVID-19 positive in the ambulatory setting...
Eligibility Criteria
Inclusion
- Age 18
- COVID 19 positive or close contact of COVID 19 positive
- No use of cardiac glycosides or other antiarrhythmic medications
Exclusion
- No use of cardiac glycosides or other antiarrhythmic medications
- No allergy to coconut oil
Key Trial Info
Start Date :
May 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 23 2020
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT04486144
Start Date
May 20 2020
End Date
July 23 2020
Last Update
April 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KDunn and Associates, PA, dba Healthquilt
Houston, Texas, United States, 77055